Roche

Penicillin-Streptomycin

Name: Penicillin-Streptomycin
Brand: ROCHE
Price: 102 USD
Availability: InStock

suitable for cell culture, lyophilized (clear, colorless solution after reconstitution), non-sterile; 0.2 μm filtered, sufficient for 20 mL

Synonym(s):

antibiotic

Slide 1 of 1

Select a Size

20 ML

$102.00

Available to ship TODAYDetails

About This Item

UNSPSC Code:

12352207

Key Documents

View All Documentation

sterility

non-sterile; 0.2 μm filtered

Quality Level

100

form

lyophilized (clear, colorless solution after reconstitution)

usage

sufficient for 20 mL

manufacturer/tradename

Roche

concentration

50 mg/mL streptomycin in 0.9% NaCl (as sulfate)
50,000 U/mL penicillin in 0.9% NaCl

technique(s)

cell culture | mammalian: suitable

antibiotic activity spectrum

Gram-negative bacteria
Gram-positive bacteria

mode of action

cell wall synthesis | interferes
protein synthesis | interferes

Storage temp.

2-8°C

Related Categories

Antibiotics

Biochemicals

Cell Culture Supplements & Reagents

Labware Partners

Roche Life Science Products

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	P4458	P4333	P7539
Roche 11074440001 Penicillin-Streptomycin	Sigma-Aldrich P4458 Penicillin-Streptomycin	Sigma-Aldrich P4333 Penicillin-Streptomycin	Sigma-Aldrich P7539 Penicillin–Streptomycin Solution Hybri-Max^™
mode of action cell wall synthesis \| interferes, protein synthesis \| interferes	mode of action cell wall synthesis \| interferes, protein synthesis \| interferes	mode of action cell wall synthesis \| interferes, protein synthesis \| interferes	mode of action cell wall synthesis \| interferes, protein synthesis \| interferes
technique(s) cell culture \| mammalian: suitable	technique(s) cell culture \| mammalian: suitable	technique(s) cell culture \| mammalian: suitable	technique(s) cell culture \| hybridoma: suitable
antibiotic activity spectrum Gram-negative bacteria, Gram-positive bacteria	antibiotic activity spectrum Gram-negative bacteria, Gram-positive bacteria	antibiotic activity spectrum Gram-negative bacteria, Gram-positive bacteria	antibiotic activity spectrum Gram-negative bacteria, Gram-positive bacteria
Quality Level 100	Quality Level 300	Quality Level 300	Quality Level 300
form lyophilized (clear, colorless solution after reconstitution)	form liquid	form liquid	form liquid
storage temp. 2-8°C	storage temp. −20°C	storage temp. −20°C	storage temp. −20°C

General description

Cytotoxic concentration: 10,000 IU/ml penicillin, 20 mg/ml streptomycin

Penicillin (Penicillin G) inhibits bacterial growth by inhibiting peptidoglycan synthesis. Streptomycin belongs to the family of aminoglycoside antibiotics, and inhibits bacterial growth by inhibiting protein synthesis. Penicillin-Streptomycin is used for the prevention and elimination of bacterial contaminants in cell culture.

Penicillin G, sodium salt; streptomycin sulfate
Sensitive organisms:

Gram-positive bacteria (penicillin)
Gram-negative bacteria (streptomycin)
Stability:Penicillin: 3 days
Streptomycin: 3 days in media at +37 °C

Application

Penicillin-Streptomycin has been used for the prevention and elimination of bacterial contaminants in cell culture.[1][2]

Physical form

Lyophilizate, 50,000 U/ml penicillin G and 50 mg/ml streptomycin (as sulfate) in 0.9% NaCl

Preparation Note

Working concentration: 100 IU/ml penicillin
100 μg/ml streptomycin

Dissolve in 20mL distilled water.

Other Notes

For life science research only. Not for use in diagnostic procedures.

pictograms

GHS07,GHS08

signalword

Danger

hcodes

H302,H317,H334,H361d

pcodes

P201 - P261 - P264 - P280 - P304 + P340 - P342 + P311

Hazard Classifications

Acute Tox. 4 Oral - Repr. 2 - Resp. Sens. 1 - Skin Sens. 1

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

does not flash

flash_point_c

does not flash

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function.

Ali Can Sahillioglu et al.

Cancer immunology research, 9(9), 999-1007 (2021-07-02)

Adoptive transfer of genetically modified or donor-derived T cells can efficiently eradicate human tumors but is also frequently associated with major toxicity. There are several switches that can be used to kill the infused cell pool in the case of

Treatment with 7% and 10% CO2 enhanced expression of IL-1β, TNF-α, and IL-6 in hypoxic cultures of human whole blood.

Hongguang Ding et al.

The Journal of international medical research, 48(4), 300060520912105-300060520912105 (2020-04-09)

Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti‑tubulin tetrahydrothieno[2,3‑c]pyridine derivative and a peptide nucleic acid targeting miR‑221‑3p.

Matteo Zurlo et al.

International journal of oncology, 59(2) (2021-07-20)

In the development of novel and more effective anticancer approaches, combined treatments appear to be of great interest, based on the possibility of obtaining relevant biological or therapeutic effects using lower concentrations of single drugs. Combination therapy may prove to

Newly established gastrointestinal cancer cell lines retain the genomic and immunophenotypic landscape of their parental cancers.

Daniela Hirsch et al.

Scientific reports, 10(1), 17895-17895 (2020-10-23)

Human cancer cell lines are frequently used as model systems to study molecular mechanisms and genetic changes in cancer. However, the model is repeatedly criticized for its lack of proximity to original patient tumors. Therefore, understanding to what extent cell

Selective BRAF inhibition decreases tumor-resident lymphocyte frequencies in a mouse model of human melanoma

Hooijkaas A, et al.

Oncoimmunology, 1(5), 609-617 (2012)

View All Related Papers